Ratings by Bernstein SocGen Group (Courtney Breen)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/7/2026 | Pfizer | PFE | Maintain | Market Perform (N/A) |
|
Details | ||
| 8/6/2026 | Amgen | AMGN | Maintain | Market Perform (N/A) |
|
Details | ||
| 7/27/2026 | Merck | MRK | Maintain | Market Perform (N/A) |
|
Details | ||
| 7/14/2026 | Eli Lilly | LLY | Maintain | Outperform (N/A) |
|
Details | ||
| 6/23/2026 | Abbvie | ABBV | Maintain | Market Perform (N/A) |
|
Details | ||
| 6/8/2026 | Eli Lilly | LLY | Maintain | Outperform (N/A) |
|
Details | ||
| 5/13/2026 | Bristol-Myers Squibb Co. | BMY | Maintain | Market Perform (N/A) |
|
Details | ||
| 5/12/2026 | Moderna | MRNA | Maintain | Market Perform (N/A) |
|
Details | ||
| 4/22/2026 | Eli Lilly | LLY | Maintain | Outperform (N/A) |
|
Details | ||
| 4/21/2026 | Eli Lilly | LLY | Maintain | Outperform (N/A) |
|
Details | ||
| 3/24/2026 | Gilead Sciences | GILD | Maintain | Outperform (N/A) |
|
Details | ||
| 3/10/2026 | Eli Lilly | LLY | Maintain | Outperform (N/A) |
|
Details | ||
| 2/25/2026 | Eli Lilly | LLY | Maintain | Outperform (N/A) |
|
Details | ||
| 2/24/2026 | Gilead Sciences | GILD | Maintain | Outperform (N/A) |
|
Details | ||
| 2/17/2026 | Moderna | MRNA | Maintain | Market Perform (N/A) |
|
Details | ||
| 2/11/2026 | Gilead Sciences | GILD | Maintain | Outperform (N/A) |
|
Details | ||
| 2/10/2026 | Pfizer | PFE | Maintain | Market Perform (N/A) |
|
Details | ||
| 2/10/2026 | Bristol-Myers Squibb Co. | BMY | Maintain | Market Perform (N/A) |
|
Details | ||
| 2/9/2026 | Eli Lilly | LLY | Maintain | Outperform (N/A) |
|
Details | ||
| 2/6/2026 | Eli Lilly | LLY | Maintain | Outperform (N/A) |
|
Details | ||
| 2/5/2026 | Abbvie | ABBV | Maintain | Market Perform (N/A) |
|
Details | ||
| 2/4/2026 | Eli Lilly | LLY | Maintain | Outperform (N/A) |
|
Details | ||
| 2/4/2026 | Merck | MRK | Maintain | Market Perform (N/A) |
|
Details | ||
| 1/20/2026 | Pfizer | PFE | Maintain | Market Perform (N/A) |
|
Details | ||
| 1/20/2026 | Merck | MRK | Maintain | Market Perform (N/A) |
|
Details | ||
| 1/20/2026 | Abbvie | ABBV | Maintain | Market Perform (N/A) |
|
Details | ||
| 1/20/2026 | Gilead Sciences | GILD | Maintain | Outperform (N/A) |
|
Details | ||
| 1/20/2026 | Eli Lilly | LLY | Maintain | Outperform (N/A) |
|
Details | ||
| 1/20/2026 | Moderna | MRNA | Maintain | Market Perform (N/A) |
|
Details | ||
| 1/20/2026 | Amgen | AMGN | Downgrade | Market Perform (Outperform) |
330.41 (425.28) |
28.71% | Details | |
| 1/8/2026 | Eli Lilly | LLY | Maintain | Outperform (N/A) |
|
Details | ||
| 12/29/2025 | Gilead Sciences | GILD | Maintain | Outperform (N/A) |
|
Details | ||
| 12/19/2025 | Eli Lilly | LLY | Maintain | Outperform (N/A) |
|
Details | ||
| 12/17/2025 | Pfizer | PFE | Maintain | Market Perform (N/A) |
|
Details | ||
| 12/11/2025 | Eli Lilly | LLY | Maintain | Outperform (N/A) |
|
Details | ||
| 11/24/2025 | Eli Lilly | LLY | Maintain | Outperform (N/A) |
|
Details | ||
| 11/24/2025 | Eli Lilly | LLY | Maintain | Outperform (N/A) |
|
Details | ||
| 11/17/2025 | Bristol-Myers Squibb Co. | BMY | Maintain | Market Perform (N/A) |
|
Details | ||
| 11/11/2025 | Moderna | MRNA | Maintain | Market Perform (N/A) |
|
Details | ||
| 11/6/2025 | Pfizer | PFE | Maintain | Market Perform (N/A) |
|
Details | ||
| 11/4/2025 | Abbvie | ABBV | Maintain | Market Perform (N/A) |
|
Details | ||
| 11/3/2025 | Bristol-Myers Squibb Co. | BMY | Maintain | Market Perform (N/A) |
|
Details | ||
| 11/3/2025 | Gilead Sciences | GILD | Maintain | Outperform (N/A) |
|
Details | ||
| 11/3/2025 | Eli Lilly | LLY | Maintain | Outperform (N/A) |
|
Details | ||
| 10/31/2025 | Pfizer | PFE | Maintain | Market Perform (N/A) |
|
Details | ||
| 10/7/2025 | Gilead Sciences | GILD | Maintain | Outperform (N/A) |
|
Details | ||
| 10/3/2025 | Amgen | AMGN | Maintain | Outperform (N/A) |
|
Details | ||
| 9/24/2025 | Eli Lilly | LLY | Maintain | Outperform (N/A) |
|
Details | ||
| 9/23/2025 | Pfizer | PFE | Maintain | Market Perform (N/A) |
|
Details | ||
| 9/17/2025 | Eli Lilly | LLY | Maintain | Outperform (N/A) |
|
Details | ||
| 8/14/2025 | Amgen | AMGN | Maintain | Outperform (N/A) |
|
Details | ||
| 8/11/2025 | Eli Lilly | LLY | Maintain | Outperform (N/A) |
|
Details | ||
| 8/5/2025 | Moderna | MRNA | Maintain | Market Perform (N/A) |
|
Details | ||
| 8/5/2025 | Abbvie | ABBV | Maintain | Market Perform (N/A) |
|
Details | ||
| 8/4/2025 | Bristol-Myers Squibb Co. | BMY | Maintain | Market Perform (N/A) |
|
Details | ||
| 8/4/2025 | Eli Lilly | LLY | Maintain | Outperform (N/A) |
|
Details | ||
| 7/9/2025 | Gilead Sciences | GILD | Maintain | Outperform (N/A) |
|
Details | ||
| 6/18/2025 | Eli Lilly | LLY | Maintain | Outperform (N/A) |
|
Details | ||
| 6/16/2025 | Eli Lilly | LLY | Maintain | Outperform (N/A) |
|
Details | ||
| 6/13/2025 | Eli Lilly | LLY | Maintain | Outperform (N/A) |
|
Details | ||
| 6/10/2025 | Merck | MRK | Maintain | Market Perform (N/A) |
|
Details | ||
| 5/20/2025 | Pfizer | PFE | Maintain | Market Perform (N/A) |
|
Details | ||
| 5/14/2025 | Eli Lilly | LLY | Maintain | Outperform (N/A) |
|
Details | ||
| 5/13/2025 | Eli Lilly | LLY | Maintain | Outperform (N/A) |
|
Details | ||
| 4/24/2025 | Moderna | MRNA | Maintain | Market Perform (N/A) |
|
Details | ||
| 4/22/2025 | Abbvie | ABBV | Maintain | Market Perform (N/A) |
|
Details | ||
| 4/22/2025 | Eli Lilly | LLY | Maintain | Outperform (N/A) |
|
Details | ||
| 4/22/2025 | Gilead Sciences | GILD | Maintain | Outperform (N/A) |
|
Details | ||
| 4/15/2025 | Pfizer | PFE | Maintain | Market Perform (N/A) |
|
Details | ||
| 4/15/2025 | Eli Lilly | LLY | Maintain | Outperform (N/A) |
|
Details | ||
| 3/25/2025 | Eli Lilly | LLY | Maintain | Outperform (N/A) |
|
Details | ||
| 3/18/2025 | Eli Lilly | LLY | Maintain | Outperform (N/A) |
|
Details | ||
| 3/18/2025 | Moderna | MRNA | Maintain | Market Perform (N/A) |
|
Details | ||
| 3/12/2025 | Gilead Sciences | GILD | Maintain | Outperform (N/A) |
|
Details | ||
| 3/6/2025 | Merck | MRK | Maintain | Market Perform (N/A) |
|
Details | ||
| 3/5/2025 | Eli Lilly | LLY | Maintain | Outperform (N/A) |
|
Details | ||
| 3/4/2025 | Abbvie | ABBV | Maintain | Market Perform (N/A) |
|
Details | ||
| 3/4/2025 | Eli Lilly | LLY | Maintain | Outperform (N/A) |
|
Details | ||
| 2/28/2025 | Eli Lilly | LLY | Maintain | Outperform (N/A) |
|
Details | ||
| 2/26/2025 | Eli Lilly | LLY | Maintain | Outperform (N/A) |
|
Details | ||
| 2/25/2025 | Pfizer | PFE | Maintain | Market Perform (N/A) |
|
Details | ||
| 2/24/2025 | Eli Lilly | LLY | Maintain | Outperform (N/A) |
|
Details | ||
| 2/20/2025 | Amgen | AMGN | Maintain | Outperform (N/A) |
|
Details | ||
| 2/17/2025 | Moderna | MRNA | Maintain | Market Perform (N/A) |
|
Details | ||
| 2/11/2025 | Merck | MRK | Maintain | Market Perform (N/A) |
|
Details | ||
| 2/6/2025 | Eli Lilly | LLY | Maintain | Outperform (N/A) |
|
Details | ||
| 1/31/2025 | Moderna | MRNA | Maintain | Market Perform (N/A) |
|
Details | ||
| 1/27/2025 | Eli Lilly | LLY | Maintain | Outperform (N/A) |
|
Details | ||
| 1/15/2025 | Eli Lilly | LLY | Maintain | Outperform (N/A) |
|
Details | ||
| 1/8/2025 | Moderna | MRNA | Maintain | Market Perform (N/A) |
|
Details | ||
| 12/20/2024 | Eli Lilly | LLY | Maintain | Outperform (N/A) |
|
Details | ||
| 12/19/2024 | Merck | MRK | Maintain | Market Perform (N/A) |
|
Details | ||
| 12/18/2024 | Pfizer | PFE | Maintain | Market Perform (N/A) |
|
Details | ||
| 12/17/2024 | Merck | MRK | Maintain | Market Perform (N/A) |
|
Details | ||
| 12/17/2024 | Gilead Sciences | GILD | Maintain | Outperform (N/A) |
|
Details | ||
| 12/12/2024 | Eli Lilly | LLY | Maintain | Outperform (N/A) |
|
Details | ||
| 12/11/2024 | Gilead Sciences | GILD | Maintain | Outperform (N/A) |
|
Details | ||
| 12/2/2024 | Merck | MRK | Maintain | Market Perform (N/A) |
|
Details | ||
| 11/26/2024 | Bristol-Myers Squibb Co. | BMY | Maintain | Market Perform (N/A) |
|
Details |
